Skip to main content
LLY
NYSE Life Sciences

Lilly Acquires 4E Therapeutics to Boost Non-Opioid Chronic Pain Pipeline

Tom Rudovsky · Reported by Reuters
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1,140
Mkt Cap
$1.074T
52W Low
$623.78
52W High
$1,182.73
52W Position info
83% above low
Off High info
3.6% below high
Rel. Volume
Market data snapshot near publication time

LLY sits 83% above its 52-week low of $623.78.

Summary

Eli Lilly has acquired 4E Therapeutics to advance its non-opioid approach to chronic pain. While the financial terms of the transaction were not disclosed, this acquisition expands Lilly's pipeline into a significant therapeutic area with high unmet need. This move follows a period of intense activity for Lilly, including the recent FDA approval and positive trial results for its weight-loss drug Foundayo, and a prior $6.3 billion acquisition of Centessa's OX2R agonist assets. It signals Lilly's continued strategic investment in diversifying its drug portfolio.

At the time of this announcement, LLY was trading at $1,140.00 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1.1T. The 52-week trading range was $623.78 to $1,182.73. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

LLY - Latest Insights

LLY
Nov 17, 2026, 11:18 AM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $1,416.23
Real-time Price: $1,399.00 info
Change: -$17.22 (-1%) info
Market Cap: $1.315T info
LLY
Nov 16, 2026, 6:52 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1,455.36
Real-time Price: $1,399.00 info
Change: -$56.36 (-4%) info
Market Cap: $1.315T info
LLY
Nov 12, 2026, 8:30 AM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $1,452.70
Real-time Price: $1,399.00 info
Change: -$53.69 (-4%) info
Market Cap: $1.315T info
LLY
Nov 12, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $1,447.85
Real-time Price: $1,399.00 info
Change: -$48.85 (-3%) info
Market Cap: $1.315T info
LLY
Nov 10, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $1,411.12
Real-time Price: $1,399.00 info
Change: -$12.12 (-0.86%) info
Market Cap: $1.315T info